Biomaterials are synthetic/natural materials that are artificially generated and employed in medical technology to improve the function of damaged tissues, bones, and organs. According to Marketstack, the Global Biomaterials Market is expected to grow considerably during the forecasted period. Factors such as the surging prevalence of musculoskeletal and chronic skeletal medical conditions are predicted to drive the Biomaterials Market in the forecasted period. Further, growth in the geriatric population, rise in prevalence rates of cardiovascular and orthopaedic disorders, and advancement in medical technology are expected to drive the Biomaterials Market in the forecasted period. Furthermore,  increasing demand for implantable devices, raised funds and grants by govt bodies and universities for developing novel biomaterials are expected to drive the Biomaterials Market in the forecasted period. However, unfavourable healthcare reforms and stringent clinical and regulatory processes are expected to obstruct market growth. Moreover, the need for more skilled surgeons, along with the limitations of biomaterial-based products, is expected to become the most significant and foremost challenge for the development of the market in the forecasted period.

The rising prevalence of chronic skeletal and musculoskeletal medical conditions is predicted to propel the demand for biomaterial-based implants, fuelling market growth. Musculoskeletal diseases are injuries to the tendons, joints, muscles, nerves, cartilage, and spinal discs. The Department of Labor's Bureau of Labor Statistics defined MSDs as musculoskeletal system and connective tissue diseases and disorders when the exposure or event that caused the condition was repetitive motion, overexertion, or bodily reaction such as bending, climbing, crawling, reaching, or twisting. The global prevalence of musculoskeletal diseases and their increasing cases, with most of the population in most countries turning towards older age, contribute to new research and development in musculoskeletal disease. Expanding the geriatric population worldwide is predicted to favour the biomaterial demand as this population is more prone to develop diseases. The number of persons above 65 will double in the coming years. Old-age people are inclined to various chronic diseases, such as cardiovascular diseases, endovascular diseases, orthopaedic disorders, and dental disorders, which can foster the demand for biomaterials across the globe. Kidney, joint, eye, and heart implants are common implantable medical devices among geriatric people. There is an increase in the cases of musculoskeletal and chronic skeletal medical conditions, which is boosting the demand for biomaterial-based implants, propelling the market's growth. The need for orthopaedic implants is also growing owing to an increase in the geriatric population and a growing risk of osteoporosis, osteoarthritis and other musculoskeletal conditions. There is also the development of several biomaterial and biomedical devices that are in demand as they help detect and treat coronavirus. There has also been an introduction of smart biomaterials, which interact with biological systems for many biomedical applications like the transportation of bioactive materials and the cellular work of engineered functional tissues. All these factors are eventually propelling the growth of the biomaterials market.

North America is projected to account for a sizeable portion of the global biomaterials market owing to the expanding target population, high adoption of cutting-edge products, and numerous pharmaceutical companies. Implantable medical devices are devices or tissues placed inside or on the body's surface. Many implants are prosthetics intended to replace missing body parts. Some other implants deliver medication, monitor body functions or support organs and tissues. The implants are placed permanently for diagnostic, monitoring, or therapeutic purposes, or they can also be removed once they are no longer needed. Long-term implants have the benefits of being in a constant-temperature environment. Dental biomaterials include polymers, metals, ceramics, and composites. The increasing burden of dental diseases such as periodontal disease, oral cancer, tooth decay, halitosis, and dental caries drives the demand for dental implants worldwide, which is expected to propel growth in the studied market. The broad availability of biopolymers and advanced polymers for bio-resorbable tissue fixation and other orthopaedic applications is also predicted to accelerate the revenue generation of the fragment. Polymeric biomaterials are one of the foundations of tissue engineering. Continuing progression in technologies, such as surface modification, drug delivery, micro-manufacturing, nanotechnology, and high-throughput screening, play an integral role in extending polymeric material usage in tissue engineering. Technological advancements have made biomaterials more adaptable and have surged their utility in various healthcare fields, such as tissue engineering and bioengineering. The rise of smart biomaterials that interact with biological systems for various biomedical applications, such as the transport of bioactive molecules to the functioning of engineered functional tissues, propels revenue generation in this market. Companies are supporting the continuing developments in novel drug delivery approaches for the limited release of drugs, thus causing market growth.

The market key players are Medtronic plc, Evonik Industries AG, Carpenter Technology Corporation, and Berkeley Advanced Biomaterials.

In April 2023, Novo Nordisk partnered with Aspect Biosystems, a company associated with bioprinting biomaterials, to develop bioprinted tissue therapeutics for obesity and diabetes.

In April 2022, DuPont announced the launch of a new spun yarn collection in collaboration with JP Modatex India, blending natural fibres with DuPont Sorona staple fibres. The collection combines linen and partially plant-based Sorona fibres to create spun yarns suitable for various applications, such as dresses, shirting, pants and skirts, denim, and jackets.

Our Global Biomaterials Market report provides deep insight into the current and future state of the market across various regions. Also, the study comprehensively analyzes the Biomaterials market by segments based on the Type (Metallic, Polymeric, Ceramic, and Natural) and Application, (Cardiovascular, Dental, Orthopaedic, Wound Healing, Plastic Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders, and Drug Delivery Systems), and by Geography (Asia Pacific, North America, Europe, South America, and Middle-East and Africa). The report examines the market drivers and restraints and the impact of COVID-19 on market growth in detail. The study covers & includes emerging market trends, market developments, market opportunities, market size, market analysis, market dynamics, and challenges in the industry. This report also covers extensively researched competitive landscape sections with profiles of prominent companies, including their market share and projects.